India and Texas Partner to Develop COVID-19 Vaccine

In COVID-19, Latest News by Precision Vaccinations

A Hyderabad-based vaccine and pharmaceutical company announced the initiation of a Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India following approval from the Drugs Controller General of India.
This early-stage study’s results are expected to be available by February 2021.

Read More